Transforming Lives with Cutting-Edge Science: Orchard Therapeutics Takes Center Stage at ASGCT Conference
Orchard Therapeutics, a global gene therapy leader, announced that six presentations from its hematopoietic stem cell (HSC) gene therapy platform will be featured at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) in Los Angeles from May 16-20, 2023. The presentations will include updated results from the company’s ongoing […]
Revolutionary Cell Therapy Shows Promise: Over 90% Seizure Reduction in Drug-Resistant Epilepsy Patients
Neurona Therapeutics, a clinical-stage biotherapeutics company, is developing regenerative cell therapies for the treatment of neurological disorders. They recently presented updated clinical data from their ongoing Phase I/II trial of NRTX-1001 in people with drug-resistant mesial temporal lobe epilepsy (MTLE) at the American Academy of Neurology 2023 Annual Meeting. The data showed a >90% reduction […]
Defying Gravity: How Space-Based Stem Cell Research Could Revolutionize Medicine
Cedars-Sinai investigators, in partnership with Axiom Space of Houston, are preparing to send stem cells to space in early May to study the effects of microgravity on their production. This groundbreaking mission, funded by NASA, will involve astronauts manufacturing induced pluripotent stem cells (iPSCs) aboard the International Space Station (ISS) for the first time. The […]
Hair Today, Gray Tomorrow? Researchers Discover Pathway to Prevent Hair Graying
A new study from NYU Grossman School of Medicine sheds light on the process of hair graying and could potentially offer a pathway to reverse or prevent it. The research focused on melanocyte stem cells (McSCs), which control hair color by maturing into pigment-producing cells. The study found that these cells have a unique ability […]
Innovative Cell Therapy, Omisirge, Receives FDA Approval to Reduce Infection Risk in Blood Cancer Treatments
The FDA has approved Omisirge (omidubicel-onlv), a modified allogeneic cord blood-based cell therapy designed to speed up the recovery of neutrophils and reduce infection risk. Omisirge is intended for use in adults and pediatric patients aged 12 and older with blood cancers who are undergoing umbilical cord blood transplantation after a myeloablative conditioning regimen. Blood […]
Boosting Stem Cell Harvest: A Promising Combo Therapy Revolutionizes Transplant Success
A recent study published in the European Pharmaceutical Review has revealed that a combination therapy can significantly improve the collection of stem cells from donors. The therapy utilizes Plerixafor, a CXCR4 antagonist, in conjunction with granulocyte-colony stimulating factor (G-CSF), which helps mobilize stem cells from bone marrow to peripheral blood. The study found that this […]
Stem Cell Therapy Shows Promise for Age-Related Macular Degeneration
A recent study has demonstrated the potential of stem cell therapy as a treatment for age-related macular degeneration (AMD), a leading cause of vision loss in older adults. Researchers from the RIKEN Center for Biosystems Dynamics Research have developed a new method of transforming stem cells into retinal cells, which has shown promising results in […]
Trailblazing Stem Cell Research: New Hope for Schizophrenia Patients
A recent study led by Dr. Sergiu Pasca at Stanford University suggests that human induced pluripotent stem cells (iPSCs) could be used to identify potential new medications for schizophrenia. The research team developed a novel technique to produce astrocytes, star-shaped cells that support neurons, from iPSCs derived from patients with schizophrenia. Astrocytes play a critical […]
BioCardia Announces Issuance of Two Patents Related to Technology That Guides Interventional Therapies
SUNNYVALE, Calif., April 04, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the issuance of two patent grants related to enabling technologies for delivery of its investigational autologous and allogeneic cell therapies. The United States Patent Office issued BioCardia Patent […]
Beyond Organ Transplants: The Power of Cell Transformation and Rejuvenation
The video discusses two major problems in modern medicine: the shortage of organs for transplantation and age-related diseases. Prof. Yossi Buganim’s lab focuses on transforming cells, such as converting skin cells into various other cell types, to create an unlimited source of cells for transplantation. This approach aims to address the organ shortage problem. Additionally, […]